Anand Shah, the US Food and Drug Administration’s deputy commissioner for medical and scientific affairs, is leaving the agency after a second stint to pursue a new career path outside government. One of FDA's top-ranking officials, he has been overseeing the agency’s COVID-19 Pandemic Recovery and Preparedness Plan.
Shah said in an interview that he had tendered his resignation on 11 January and would be leaving next week,...






